Search
for
Sort by
Research 61–90 of 274
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Stem Cells and the Niche: A Dynamic Duo
- How to diagnose a lipodystrophy syndrome
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Ginsenoside Rb1 promotes the growth of mink hair follicle via PI3K/AKT/GSK-3β signaling pathway
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Clinical manifestations of polycystic ovary syndrome
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Can gut flora changes be new biomarkers for depression?
- Caring for women with polycystic ovary syndrome
- Exploring the Causal Relationship and Molecular Mechanisms Between Fasting Insulin and Androgenetic Alopecia: A Mendelian Randomization Study with Bioinformatics Analysis
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries
- Skin manifestations of hyperandrogenism: an update
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- The Impact of Bariatric Surgery on the Development and Progression of Dermatologic Diseases: A Narrative Review
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Understanding Polycystic Ovary Syndrome
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Clinical aspects of the metabolic syndrome
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Exploring Hirsutism: Epidemiology, Associated Endocrinal Abnormalities, and Societal Challenges in GCC—A Narrative Review
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring